The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings

Multiple sclerosis and cancer in Norway A retrospective cohort study

(2010) R. Midgard et al.   ACTA NEUROLOGICA SCANDINAVICA

Interferons and multiple sclerosis: is it plausible that β-IFN treatment could influence the risk of cancer among MS patients?

(2009) Elaine Kingwell et al.   Expert Review of Neurotherapeutics

Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies

(2009) A. F Fois et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?

(2009) R Ellis et al.   Multiple Sclerosis Journal

Cancer risk among patients with multiple sclerosis and their parents

(2009) S. Bahmanyar et al.   NEUROLOGY

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis

(2008) Christine Lebrun et al.   Multiple Sclerosis Journal